Loading organizations...
Loading organizations...
Biotech company developing RNA-based therapeutics for neuroinflammation.
BIORCHESTRA has raised $45.0M across 1 funding round.
BIORCHESTRA has raised $45.0M in total across 1 funding round.
BIORCHESTRA has raised $45.0M in total across 1 funding round.
BIORCHESTRA's investors include Chong Kun Dang Holdings, Chong Kun Dang Pharmaceutical, Daily Partners, E&Venture Partners, GS Holdings, IMM Investment, LSK Investment, NH Investment & Securities, Quantum Ventures Korea, SBI Investment, Smilegate Investment, Stick Investment.
BIORCHESTRA has raised $45.0M across 1 funding round. Most recently, it raised $45.0M Series C in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 28, 2022 | $45.0M Series C | Chong Kun Dang Holdings, Chong Kun Dang Pharmaceutical, Daily Partners, E&Venture Partners, GS Holdings, IMM Investment, LSK Investment, NH Investment & Securities, Quantum Ventures Korea, SBI Investment, Smilegate Investment, Stick Investment, Widwin Investment |